A Phase 3, Multi-Center, Randomized, Double-blind, Placebo-Controlled, Safety, Tolerability, and Efficacy Study of Oxycodone DETERx Versus Placebo in Opioid-Experienced and Opioid-Naive Subjects With Moderate-to-Severe Chronic Low Back Pain
Phase of Trial: Phase III
Latest Information Update: 05 Sep 2017
At a glance
- Drugs Oxycodone (Primary)
- Indications Back pain
- Focus Registrational; Therapeutic Use
- Sponsors Collegium Pharmaceutical
- 05 Sep 2017 According to a Collegium Pharmaceutical media release, data of post hoc analysis from this study will be presented during the poster session at PAINWeek 2017.
- 09 Aug 2017 According to a Collegium Pharmaceutical media release, results of post hoc analysis from this study have been published in the Drugs and Aging, June 2017.
- 16 Mar 2017 According to a Collegium media release, post hoc analysis data will be presented at the 33rd Annual American Academy of Pain Medicine Meeting.